BioMarin Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	348.9	426.86	167.65	141.56	-64.08
Depreciation & Amortization	79.56	96.43	104.39	101.97	108.04
Stock-Based Compensation	181.41	201.57	207.1	196.31	197.26
Other Adjustments	511.79	64.38	16.67	-167.55	-2.72
Change in Receivables	-228.05	-57.91	-190.44	-82.03	65.57
Changes in Inventories	-116.93	-63.53	-157.06	-68.26	-35.06
Changes in Accounts Payable	66.14	-32.24	68.85	59.02	15.69
Changes in Other Operating Activities	-14.81	-62.72	-57.9	-5.1	19.83
Operating Cash Flow	827.99	572.84	159.26	175.9	304.54
Operating Cash Flow Growth	44.54%	259.69%	-9.46%	-42.24%	256.75%
Capital Expenditures	-103.04	-85.42	-96.69	-120.96	-95.58
Sale of Property, Plant & Equipment	-	10	-	103.33	-
Purchases of Intangible Assets	-7.94	-11.99	-10.92	-10.58	-23.65
Purchases of Investments	-355.88	-410.25	-868.5	-611.81	-937.14
Proceeds from Sale of Investments	337.8	633.02	864.86	620	691.05
Payments for Business Acquisitions	-285.19	-	-	-	-
Other Investing Activities	1.14	-	-	-	-0.99
Investing Cash Flow	-414.24	136.49	-111.24	-20.03	-366.31
Long-Term Debt Repaid	-	-494.99	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-494.99	-	-	-
Issuance of Common Stock	14.46	49.28	69.35	69.33	49.19
Repurchase of Common Stock	-55.97	-77.56	-76.32	-54.28	-45.81
Net Common Stock Issued (Repurchased)	-41.51	-28.28	-6.97	15.05	3.39
Other Financing Activities	-0.89	-3.18	-11.76	-33.7	-3.44
Financing Cash Flow	-42.39	-526.45	-18.73	-18.65	-0.05
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-2.52	4.83	1.31	0.03	-0.06
Net Cash Flow	368.84	187.72	30.6	137.26	-61.88
Free Cash Flow	724.96	487.42	62.57	54.94	208.96
Free Cash Flow Growth	48.73%	679.02%	13.88%	-73.71%	-
FCF Margin	22.51%	17.08%	2.59%	2.62%	11.32%
Free Cash Flow Per Share	3.67	2.48	0.33	0.29	1.14
Levered Free Cash Flow	259.81	-215.61	29.24	108.22	-51.16
Unlevered Free Cash Flow	207.02	234.03	26.76	119.01	-57.1

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.